For many patients suffering from Coronary Microvascular Dysfunction (CMD), seeking a definitive diagnosis typically means years of burdensome, costly, and inconclusive testing.
Read what patients and physicians alike think about the potential CardioFlux MCG has to change the standard of care in diagnosing CMD.
Amber
CMD Patient
Cindy
CMD Patient
Dr. Odayme Quesada
Medical Director, The Christ Hospital Women's Heart Center
Dr. Robert Takla
Genetesis Chief Medical Officer
Peeyush Shrivastava
Genetesis CEO
Jill
CMD Patient
Amber G.
Coronary Microvascular Dysfunction Patient